Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (21)

2019

  1. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly

    EBioMedicine, Vol. 43, pp. 537-552

2017

  1. Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age

    Oncology Letters, Vol. 13, Núm. 5, pp. 3501-3507

  2. Long-term outcome of multimodal therapy for giant prolactinomas

    Endocrine, Vol. 55, Núm. 1, pp. 231-238

  3. Tumor de células esteroideas sin otra especificación: reporte de un caso

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 44, Núm. 3, pp. 129-133

2015

  1. Thyroid pathology findings in Cowden syndrome: A clue for the diagnosis of the PTEN hamartoma tumor syndrome

    American Journal of Clinical Pathology, Vol. 144, Núm. 2, pp. 322-328

2013

  1. Adrenal carcinoma: A retrospective analysis of our series

    Endocrinologia y Nutricion

  2. Hemiagenesia tiroidea: Registro de 5 casos y revisión de la literatura

    Endocrinologia y Nutricion

  3. Pegvisomant and cabergoline combination therapy in acromegaly

    Pituitary, Vol. 16, Núm. 1, pp. 101-108

2011

  1. Gangliocitoma hipofisario no funcionante

    Endocrinologia y Nutricion

  2. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis

    Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188

  3. Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)

    Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271

  4. Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus

    Diabetes Research and Clinical Practice, Vol. 91, Núm. 3

2010

  1. Primary thyroid tuberculosis

    Endocrinologia y Nutricion

  2. Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy

    Diabetic Medicine, Vol. 27, Núm. 10, pp. 1178-1187

2009

  1. Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus

    Chronobiology International, Vol. 26, Núm. 5, pp. 942-957

2008

  1. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain

    European Journal of Endocrinology, Vol. 159, Núm. 5, pp. 623-631

  2. Severe hypertension and hypokalemia as first clinical manifestations in ectopic Cushing's syndrome

    Arquivos Brasileiros de Endocrinologia e Metabologia, Vol. 52, Núm. 6, pp. 1066-1070

2006

  1. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect

    Clinical Endocrinology, Vol. 64, Núm. 3, pp. 330-336

2005

  1. Update on radioiodine treatment: Use of recombinant human thyroid-stimulating hormone treatment

    Endocrinologia y Nutricion, Vol. 52, Núm. SUPPL. 1, pp. 18-22

1997

  1. L-hydroxytryptophan amplifies pulsatile secretion of LH in the follicular phase of normal women

    Clinical Endocrinology, Vol. 47, Núm. 5, pp. 555-563